Pediatric Cancer.

Abstract

In pediatric brain tumors, the intensification of chemotherapy has allowed for a reduction in radiotherapy (RT) volume to an involved field approach, particularly in patients with medulloblastoma. For patients with low-grade gliomas, the trend has remained to delay RT with chemotherapy; however, when RT is used, typically smaller clinical target volume margins are used. For patients with extracranial tumors, intensive chemotherapy to address systemic disease with local control is considered standard. Proton beam therapy shows significant promise in addressing both short-term and long-term toxicities in both central nervous system (CNS) and non-CNS pediatric tumors.

• Authors: Sujith Baliga, Torunn I Yock
• Journal: Hematology/oncology clinics of North America (Hematol Oncol Clin North Am) Vol. 34 Issue 1 Pg. 143-159 (02 2020) ISSN: 1558-1977 [Electronic] United States
• PMID: 31739941 (Publication Type: Journal Article, Review)
• Copyright: Copyright © 2019 Elsevier Inc. All rights reserved.

Topics

• Adolescent
• Brain Neoplasms (mortality, therapy)
• Child
• Child, Preschool
• Disease-Free Survival
• Female
• Humans
• Infant
• Infant, Newborn
• Leukemia (mortality, therapy)
• Lymphoma (mortality, therapy)
• Male
• Survival Rate